Rhythm Pharmaceuticals, Inc. (RYTM)
104.71
+2.51
(+2.46%)
USD |
NASDAQ |
Sep 11, 16:00
104.50
-0.21
(-0.20%)
After-Hours: 06:35
Rhythm Pharmaceuticals Price to Book Value : 69.97 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 69.97 |
| September 10, 2026 | 68.29 |
| September 09, 2026 | 67.53 |
| September 08, 2026 | 68.03 |
| September 04, 2026 | 68.65 |
| September 03, 2026 | 70.09 |
| September 02, 2026 | 70.45 |
| September 01, 2026 | 69.99 |
| August 31, 2026 | 70.92 |
| August 28, 2026 | 71.61 |
| August 27, 2026 | 75.20 |
| August 26, 2026 | 74.76 |
| August 25, 2026 | 75.74 |
| August 24, 2026 | 74.47 |
| August 21, 2026 | 73.51 |
| August 20, 2026 | 72.78 |
| August 19, 2026 | 77.33 |
| August 18, 2026 | 77.01 |
| August 17, 2026 | 77.14 |
| August 14, 2026 | 77.17 |
| August 13, 2026 | 77.53 |
| August 12, 2026 | 78.58 |
| August 11, 2026 | 75.41 |
| August 10, 2026 | 77.17 |
| August 07, 2026 | 77.27 |
| Date | Value |
|---|---|
| August 06, 2026 | 74.91 |
| August 05, 2026 | 73.98 |
| August 04, 2026 | 70.69 |
| August 03, 2026 | 68.68 |
| July 31, 2026 | 66.32 |
| July 30, 2026 | 70.66 |
| July 29, 2026 | 71.19 |
| July 28, 2026 | 72.20 |
| July 27, 2026 | 70.92 |
| July 24, 2026 | 68.23 |
| July 23, 2026 | 68.60 |
| July 22, 2026 | 69.48 |
| July 21, 2026 | 71.23 |
| July 20, 2026 | 69.90 |
| July 17, 2026 | 71.23 |
| July 16, 2026 | 70.89 |
| July 15, 2026 | 73.30 |
| July 14, 2026 | 73.48 |
| July 13, 2026 | 71.83 |
| July 10, 2026 | 72.44 |
| July 09, 2026 | 77.17 |
| July 08, 2026 | 76.47 |
| July 07, 2026 | 76.49 |
| July 06, 2026 | 74.63 |
| July 02, 2026 | 76.29 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.666 |
| Alnylam Pharmaceuticals, Inc. | 24.56 |
| BioMarin Pharmaceutical, Inc. | 2.011 |
| Cytokinetics, Inc. | -- |
| Exelixis, Inc. | 7.576 |
Price to Book Value Related Metrics
| PS Ratio | 29.43 |
| PEG Ratio | -10.15 |
| Price | 104.71 |
| Earnings Yield | -2.98% |
| Market Cap | 7.206B |
| PEGY Ratio | -10.15 |